ArticleCurrent neuropharmacology2017

Tumour-Derived Glutamate: Linking Aberrant Cancer Cell Metabolism to Peripheral Sensory Pain Pathways.

Jennifer Fazzari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.